Steven Nijs

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 342 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

Johan Vingerhoets, Lotke Tambuyzer, Hilde Azijn et al. · AIDS · 2010 · 185 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

Christine Katlama, Bonaventura Clotet, Anthony Mills et al. · Antiviral Therapy · 2010 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

Lindsey R. Baden, Daniel J Stieh, Michal Sarnecki et al. · The Lancet HIV · 2020 · 91 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase on Phenotypic Susceptibility and Virologic Response to Etravirine

Lotke Tambuyzer, Steven Nijs, Bjorn Daems et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 78 citations

Life Sciences, Infectious Diseases, Molecular Biology +17